What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-04-01 compared with 2025-03-28 · 59 added, 49 removed, 1 unchanged (99% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

common stock is listed on The Nasdaq Capital Market and its stock symbol is “JUNS.” The closing price of our common stock

on The Nasdaq Capital Market on March 28, 2025 was $0.70.

of March 28, 2025, there were 33,103,860 shares of common stock issued and outstanding, and we had approximately 31 holders

of record of our common stock.

The number of record holders does not include beneficial owners of common stock whose shares are

held in the names of banks, brokers, nominees or other fiduciaries.

have not declared or paid any cash dividends on our common stock since our inception, and do not currently anticipate paying cash dividends

in the foreseeable future.

We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.

Authorized for Issuance Under Equity Compensation Plans

Company’s stockholders approved the 2016 Equity Incentive Plan (“2016 Plan”) on January 4, 2016.

Under the 2016 Plan,

as modified, 8,437,500 shares of common stock are authorized for issuance to employees, officers, directors, consultants.

The 2016 Plan

authorizes the grant of nonqualified stock options and incentive stock options, restricted stock awards, restricted stock units, stock

appreciation rights, under the 2016 Plan.

The Company does not intend to make any grants under the 2016 Plan.

Board of Directors and stockholders of the Company approved the 2021 Equity Incentive Plan (the “2021 Plan”) on September

Under the 2021 Plan, 1,125,000 shares of common stock are authorized for issuance to employees, directors and independent contractors

(except those performing services in connection with the offer or sale of the Company’s securities in a capital raising transaction,

or promoting or maintaining a market for the Company’s securities.

The 2021 Plan authorizes equity-based and cash-based incentives

for participants.

On July 22, 2022, the Board of Directors increased the shares authorized in the 2021 Plan, increasing the plan to 1,710,000.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED

STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed on The Nasdaq

Capital Market and its stock symbol is “JUNS.” The closing price of our common stock on The Nasdaq Capital Market on March 30, 2026 was $0.3248.

As of March 31, 2026, there were 36,281,252 shares of common stock issued and outstanding, and we had approximately 29 holders of record of our common stock.

The number of record

holders does not include beneficial owners of common stock whose shares are held in the names of banks, brokers, nominees or other fiduciaries.

We have not declared or paid any cash

dividends on our common stock since our inception, and do not currently anticipate paying cash dividends in the foreseeable future.

intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.

Securities Authorized for Issuance Under Equity Compensation

The Company’s stockholders approved

the 2016 Equity Incentive Plan (“2016 Plan”) on January 4, 2016.

Under the 2016 Plan, as modified, 8,437,500 shares of common

stock are authorized for issuance to employees, officers, directors, consultants.

The 2016 Plan authorizes the grant of nonqualified stock

options and incentive stock options, restricted stock awards, restricted stock units, stock appreciation rights, under the 2016 Plan.

The Company does not intend to make any grants under the 2016 Plan.

Board of Directors and stockholders of the Company approved the 2023 Equity Incentive Plan (the “2023 Plan”) on October 4,

Under the 2023 Plan, 4,012,785 shares of common stock are authorized for issuance to employees, directors and independent contractors

(except those performing services in connection with the offer or sale of the Company’s securities in a capital raising transaction,

or promoting or maintaining a market for the Company’s securities) of the Company or its subsidiaries.

As of March 28, 2025,

there were 2,139,240 shares available for issuance under the 2023 Plan.

Sales of Unregistered Securities

Non-qualified

Stock Option;

Eschenburg Perez, our former Chief Financial Officer

Non-qualified

Stock Option;

Restricted Stock

Eschenburg Perez, our former Chief Financial Officer

Non-qualified

Stock Option;

Non-qualified

Stock Option;

above issuances/sales were made pursuant to an exemption from registration as set forth in Section 4(a)(2) of the Securities Act and/or

Rule 506 of Regulation D promulgated under the Securities Act.

of Equity Securities by the Issuer and Affiliated Purchasers

Company’s transfer agent is Equiniti Trust Company.

The transfer agent’s address is 1110 Centre Pointe Curve, Suite 101,

Mendota Heights, Minnesota 55120, and its telephone number is (800) 401-1957.

The Board of Directors and stockholders

of the Company approved the 2021 Equity Incentive Plan (the “2021 Plan”) on September 17, 2021.

Under the 2021 Plan, 1,125,000

shares of common stock are authorized for issuance to employees, directors and independent contractors (except those performing services

in connection with the offer or sale of the Company’s securities in a capital raising transaction, or promoting or maintaining a

market for the Company’s securities.

The 2021 Plan authorizes equity-based and cash-based incentives for participants.

2022, the Board of Directors increased the shares authorized in the 2021 Plan, increasing the plan to 1,710,000.

The Company does not

intend to make any grants under the 2021 Plan.

The Board of Directors and stockholders

of the Company approved the 2023 Equity Incentive Plan (the “2023 Plan”) on October 4, 2023.

Under the 2023 Plan, 4,012,785

shares of common stock are authorized for issuance to employees, directors and independent contractors (except those performing services

in connection with the offer or sale of the Company’s securities in a capital raising transaction, or promoting or maintaining a

market for the Company’s securities) of the Company or its subsidiaries.

As of March 31, 2026, there were 1,047,135 shares available

for issuance under the 2023 Plan.

The Board of Directors and stockholders

of the Company approved the 2025 Equity Incentive Plan (the “2025 Plan”) on December 19, 2025.

Under the 2025 Plan, 5,250,000

shares of common stock are authorized for issuance to employees, directors and independent contractors (except those performing services

in connection with the offer or sale of the Company’s securities in a capital raising transaction, or promoting or maintaining a

market for the Company’s securities) of the Company or its subsidiaries.

As of March 31, 2026, there were 5,250,000 shares available

for issuance under the 2025 Plan.

Recent Sales of Unregistered Securities

Type of Award

A service provider

April 23, 2025

A service provider

April 23, 2025

The above issuances/sales were made pursuant

to an exemption from registration as set forth in Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under

the Securities Act.

Purchases of Equity Securities by the Issuer and Affiliated

Transfer Agent

The Company’s transfer agent is

Equiniti Trust Company.

The transfer agent’s address is 1110 Centre Pointe Curve, Suite 101, Mendota Heights, Minnesota 55120, and

its telephone number is (800) 401-1957.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity